The Food and Drug Administration withheld vital information on an anti-pneumonia drug from one of the agency’s own advisory panels, a U.S. senator charged.

“The Foodand Drug Administration can’t be in the business of misleading the public and hiding the truth,” Sen. Chuck Grassley, R-Iowa, said in a news release.